SINOPHARM Financial Statements From 2010 to 2024
| SHTDY Stock | USD 12.80 0.35 2.66% |
Check SINOPHARM GROUP financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among SINOPHARM GROUP's main balance sheet or income statement drivers, such as , as well as many indicators such as . SINOPHARM financial statements analysis is a perfect complement when working with SINOPHARM GROUP Valuation or Volatility modules.
SINOPHARM |
SINOPHARM GROUP LTD Company Return On Equity Analysis
SINOPHARM GROUP's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current SINOPHARM GROUP Return On Equity | 0.13 |
Most of SINOPHARM GROUP's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, SINOPHARM GROUP LTD is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, SINOPHARM GROUP LTD has a Return On Equity of 0.1319. This is 100.55% lower than that of the Healthcare sector and 98.23% lower than that of the Medical Distribution industry. The return on equity for all United States stocks is 142.55% lower than that of the firm.
SINOPHARM GROUP LTD Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining SINOPHARM GROUP's current stock value. Our valuation model uses many indicators to compare SINOPHARM GROUP value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across SINOPHARM GROUP competition to find correlations between indicators driving SINOPHARM GROUP's intrinsic value. More Info.SINOPHARM GROUP LTD is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers reporting about 0.28 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for SINOPHARM GROUP LTD is roughly 3.62 . Comparative valuation analysis is a catch-all model that can be used if you cannot value SINOPHARM GROUP by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for SINOPHARM GROUP's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About SINOPHARM GROUP Financial Statements
SINOPHARM GROUP investors use historical fundamental indicators, such as SINOPHARM GROUP's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in SINOPHARM GROUP. Please read more on our technical analysis and fundamental analysis pages.
Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the Peoples Republic of China. Ltd. is a subsidiary of Sinopharm Industrial Investment Co., Ltd. Sinopharm is traded on OTC Exchange in the United States.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for SINOPHARM Pink Sheet Analysis
When running SINOPHARM GROUP's price analysis, check to measure SINOPHARM GROUP's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SINOPHARM GROUP is operating at the current time. Most of SINOPHARM GROUP's value examination focuses on studying past and present price action to predict the probability of SINOPHARM GROUP's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SINOPHARM GROUP's price. Additionally, you may evaluate how the addition of SINOPHARM GROUP to your portfolios can decrease your overall portfolio volatility.